homocysteine has been researched along with Cardiovascular Stroke in 267 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (1.50) | 18.7374 |
| 1990's | 48 (17.98) | 18.2507 |
| 2000's | 140 (52.43) | 29.6817 |
| 2010's | 62 (23.22) | 24.3611 |
| 2020's | 13 (4.87) | 2.80 |
| Authors | Studies |
|---|---|
| Bajic, Z; Djuric, DM; Matavulj, A; Ponorac, N; Skrbic, R; Sobot, T; Stojiljkovic, MP | 1 |
| Chen, D; Wang, L; Wu, Y; Xiang, Y; Xie, C; Zhan, Y; Zhang, Z | 1 |
| Chen, K; Fan, L; Fang, X; Gao, Y; Guo, JJ; Han, J; Li, J; Lin, J; Liu, L; Su, X; Wang, H; Xu, W; Yang, L; Yang, Y; Zhao, L | 1 |
| Jakubowski, H; Perła-Kaján, J; Sikora, M; Skrzydlewski, P | 1 |
| Hou, HM; Qin, XJ; Zhao, HY | 1 |
| Gao, W; Guo, J; Guo, S; Jia, C; Ren, L; Zhao, W; Zuo, R | 1 |
| Feng, F; Li, HD; Wang, BB; Yu, H; Zhao, M | 1 |
| Li, H; Li, T; Shi, L; Wang, Q | 1 |
| Back, JH; Choi, Y; Jee, SH; Khan, A; Lee, S; Park, YH | 1 |
| Bao, H; Cheng, X; Deng, H; Hu, X; Huang, X; Wan, K; Wang, D; Wang, H; Wu, Q; Xu, Z; Zhan, B; Zhang, Y | 1 |
| Boricic, N; Bozic Nedeljkovic, B; Celic, V; Djuric, D; Ilic, A; Mutavdzin, S; Simic, T; Stankovic, S; Stevanovic, P; Todorovic, D | 1 |
| Deng, GX; Li, H; Miao, L; Nie, RJ; Wang, Y; Yang, S; Yin, RX | 1 |
| Zhang, J; Zhao, Y | 1 |
| Haider, G; Iqbal, K; Iqbal, MP; Iqbal, SP; Mehboobali, N; Parveen, S; Tareen, AK | 1 |
| Ahluwalia, J; Das, R; Dogra, RK; Jamwal, M; Rohit, MK; Sharma, P; Vishwajeet, V | 1 |
| Bjørnestad, EØ; Borsholm, RA; Bønaa, KH; Midttun, Ø; Nygård, O; Pedersen, ER; Seifert, R; Svingen, GFT; Tell, GS; Ueland, PM | 1 |
| Geng, XB; Hong, Y; Li, L; Ma, Y; Shang, XM; Tan, Z; Wang, JH; Wang, YJ | 1 |
| Cao, F; Chen, Y; Dong, W; Fu, Z; Guo, J; Qian, G; Shen, M; Xue, H; Yang, X | 1 |
| Blomhoff, R; Dhar, I; Midttun, Ø; Nygård, OK; Olsen, T; Pedersen, ER; Refsum, H; Svingen, GF; Tell, GS; Ueland, PM; Vinknes, KJ | 1 |
| Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M | 1 |
| Puddu, PE | 1 |
| Li, Y; Liu, J; Quan, J; Wu, Y; Yang, L | 1 |
| Chen, Z; Dong, Y; Kang, Y; Shao, L; Tian, Y; Wang, J; Wang, X; Wang, Z; Zhang, L; Zheng, C | 1 |
| Gao, J; Li, J; Li, XW; Si, J; Wang, Y; Wu, QQ; Zhang, LM; Zhang, YH; Zuo, XB | 1 |
| Fang, S; Wu, J; Zhou, C | 1 |
| Han, J; Li, L; Liu, N; Liu, X; Liu, Z; Lv, Y; Shi, M; Wang, B; Wang, L; Wu, S; Xia, F; Yang, F; Zhao, G | 1 |
| Baudin, B; Chalghoum, A; Chkioua, L; Ernez, S; Ferchichi, S; Miled, A; Noichri, Y | 1 |
| De Geest, B; Gordts, SC; Jacobs, F; Muthuramu, I; Singh, N | 1 |
| Eliasson, M; Hallmans, G; Hultdin, J; Jansson, JH; Johnson, O; Söderström, E; Weinehall, L | 1 |
| Berg, C; Björck, L; Blennow, K; de Faire, U; Leander, K; Lissner, L; Mehlig, K; Nyberg, F; Rosengren, A; Strandhagen, E; Thelle, D; Tognon, G; Torén, K; Zetterberg, H | 1 |
| Di Gaetano, C; Fiorito, G; Frasca, G; Grioni, S; Guarrera, S; Iacoviello, L; Krogh, V; Mattiello, A; Matullo, G; Modica, F; Panico, S; Ricceri, F; Rosa, F; Russo, A; Sacerdote, C; Tumino, R; Valle, C; Vineis, P | 1 |
| Jia, X; Liu, H; Pan, H; Wang, C; Wang, Y; Xie, J; Yang, Y; Yao, M | 1 |
| Barbieri, L; Cassetti, E; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Verdoia, M | 1 |
| Campana, C; Kobe, D; Peoples, K; Simon, E | 1 |
| Arshi, B; Markovic, D; Ovbiagele, B; Towfighi, A | 1 |
| Baszczuk, A; Kopczyński, Z | 1 |
| Ahluwalia, J; Das, R; Kaur, R; Kumar, RM; Talwar, KK | 1 |
| Akbal, E; Akyürek, Ö; Güneş, F | 1 |
| Ren, MY; Zhang, CS; Zhang, XJ; Zhong, JQ | 1 |
| Cass, A; Gallagher, MP; Jardine, MJ; Kang, A; Kulshrestha, S; Navaneethan, SD; Nigwekar, SU; Perkovic, V; Strippoli, GF; Zoungas, S | 1 |
| Bickel, C; Blankenberg, S; Lackner, K; Lubos, E; Proust, C; Rupprecht, H; Schnabel, RB; Sinning, C; Tregouet, D; Westermann, D; Zengin, E | 1 |
| Hu, GX; Li, YH; Mou, L; Qiao, LJ; Tian, YG; Zhang, J | 1 |
| Bravo-Soto, GA; Madrid, T | 1 |
| Schooling, CM; Zhao, JV | 1 |
| Almeida, BR; Brito, CJ; Córdova, C; Daros, AC; Ferreira, AP; Gomes, L; Machado-Silva, W; Moraes, CF; Nóbrega, OT; Paula, RS; Souza, VC | 1 |
| Claessen, BE; Clappers, N; Jansen, JB; Laheij, RJ; Peters, WH; van Oijen, MG; van Schaik, A; Verheugt, FW | 1 |
| Achouri, A; Ben Ali, S; Elasmi, M; Feki, M; Jemaa, R; Kaabachi, N; Kallel, A; Mechmeche, R; Mourali, S; Omar, S; Sanhaji, H; Taieb, SH | 1 |
| Lavie, CJ; Milani, RV | 1 |
| Eren, M; Kucukoglu, S; Mutlu, H; Nurkalem, Z; Okcun, B; Okuyan, E; Orhan, AL; Sayar, N; Soylu, O; Uslu, N; Yildiz, A | 1 |
| Lorenzl, S | 1 |
| Anandan, R; AnbinEzhilan, R; Buddhan, S; Ganesan, B; Sivakumar, R | 1 |
| Eliasson, M; Hallmans, G; Hultdin, J; Jansson, JH; Johansson, I; Palmqvist, R; Van Guelpen, B; Weinehall, L; Winkvist, A; Witthöft, C | 1 |
| Arslanagić, A; Dzubur, A; Hadzović-Dzuvo, A; Lepara, O; Nakas-Ićindić, E; Valjevac, A; Zaćiragić, A | 1 |
| Lutz, UC | 1 |
| Kadota, J; Naono, S; Tamura, A | 1 |
| Chiuve, SE; Ma, J; Manson, JE; Page, JH; Rimm, EB; Selhub, J; Stampfer, MJ | 2 |
| Eshraghian, A; Izadi, HR; Naghshvar, F; Pourahmad, M; Shojaie, M | 1 |
| Armitage, JM; Bowman, L; Bulbulia, R; Clarke, RJ; Collins, R; Haynes, R; Parish, S; Peto, R; Rahimi, K; Sleight, P; Wallendszus, K | 1 |
| Arnesen, E; Bleie, Ø; Bønaa, KH; Ebbing, M; Fredriksen, A; Midttun, Ø; Nilsen, DW; Njølstad, I; Nordrehaug, JE; Nygård, O; Pedersen, ER; Rasmussen, K; Refsum, H; Schirmer, H; Steigen, T; Tverdal, A; Ueland, PM; Vollset, SE | 1 |
| Givvimani, S; Lominadze, D; Metreveli, N; Qipshidze, N; Sen, U; Tyagi, N; Tyagi, SC | 1 |
| Chan, MT; Forbes, A; Leslie, K; Myles, PS; Paech, MJ; Peyton, P; Silbert, BS; Williamson, E | 1 |
| Akar Bayram, N; Akçay, M; Ayhan, H; Bozkurt, E; Durmaz, T; Keleş, T; Yeter, E | 1 |
| Hatcher, NL | 1 |
| Agoşton-Coldea, L; Gatfossé, M; Mocan, T; Rosenstingl, S; Seicean, A | 1 |
| Badner, NH; Beattie, WS | 1 |
| Agoston-Coldea, L; Dumitrascu, DL; Gatfosse, M; Lupu, S; Mocan, T | 1 |
| Agoşton-Coldea, L; Dobie, L; Lupu, S; Mărginean, A; Mocan, T | 1 |
| Deng, Y; Duan, Y; Guo, J; Kuang, D; Wan, J; Wang, G; Xiao, G; Zhu, Y | 1 |
| Huque, MM; M Giasuddin, AS; Mujibul Haq, AM | 1 |
| Choi, D; Choi, KH; Han, SH; Hong, MK; Jang, Y; Kang, SW; Kim, BK; Kim, JS; Kim, SJ; Ko, YG; Yoo, TH | 1 |
| Balogh, E; Bereczky, Z; Czuriga, I; Edes, I; Katona, E; Koszegi, Z; Muszbek, L | 1 |
| Hirayama, A; Nagao, K; Nomoto, K; Tani, S; Washio, T; Watanabe, I | 1 |
| Cao, WW; Cao, Y; Chang, BB; Chen, YC; Liu, XQ; Yang, WL; Zhang, L | 1 |
| Carru, C; Deiana, L; Scanu, B; Sotgia, S; Talanas, G; Terrosu, P; Zinellu, A | 1 |
| Alam, N; Ali, MS; Amin, MG; Chowdhury, AW; Haque, MS; Khan, HI; Sabah, KM | 1 |
| Atkinson, W; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Lever, M; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW | 1 |
| Chen, Y; Huang, T; Li, D; Wahlqvist, ML; Yang, B; Yang, J | 1 |
| Abdessalem, S; Feki, M; Jemaa, R; Kaabachi, N; Kallel, A; Mechmeche, R; Mourali, MS; Sediri, Y | 1 |
| Ankrah, A; Buscombe, J; Sathekge, MM | 1 |
| Gjessing, HK; Igland, J; Nygård, OK; Tell, GS; Ueland, PM; Vollset, SE | 1 |
| Markovic, D; Ovbiagele, B; Towfighi, A | 1 |
| Ceyhan, BM; Dogan, A; Erdogan, D; Ozaydin, M; Sutcu, R; Turker, Y; Yucel, H | 1 |
| Idris, S; McIlwee, A; Ukachukwu, V | 1 |
| Campolo, J; Cozzi, L; De Maria, R; Marocchi, A; Parodi, O; Parolini, M; Patrosso, MC; Penco, S | 1 |
| Huang, T; Li, D | 1 |
| Doolman, R; Freimark, D; Goldenberg, I; Guetta, V; Hod, H; Hodish, I; Matetzky, S; Sela, BA; Selah, BA | 1 |
| Acikel, M; Bozkurt, E; Erol, MK; Gurlertop, Y; Keles, S; Yilmaz, M | 1 |
| Cândido, A; Cardim, N; Castela, S; Cordeiro, R; Correia, JF; Correia, MJ; Duarte, R; Gomes, E; Lobo, JL; Ramos, A; Reis, RP | 1 |
| Deicher, R; Vierhapper, H | 1 |
| RuDusky, BM | 1 |
| Rambihar, VS | 1 |
| Chan, SP; Cheng, A; Ng, KC; Yong, QW | 1 |
| Burke, AP; Fink, L; Fonseca, V; Kolodgie, F; Virmani, R; Zieske, A | 1 |
| Ambrosi, P; Artaud-Navarro, A; Barlatier, A; Boussuges, A; Bouvenot, G; Ferracci, A; Garçon, D; Habib, G; Luccioni, R | 1 |
| Bakken, A; Berg, K; Bohn, M; Erikssen, J; Malinow, MR; Paus, B; Retterstol, L | 1 |
| Beiser, A; D'Agostino, RB; Jacques, PF; Levy, D; Rosenberg, IH; Selhub, J; Vasan, RS; Wilson, PW | 1 |
| Meissner, T | 1 |
| Ben-Ami, S; Doolman, R; Eldar, M; Freimark, D; Goldenberg, I; Hod, H; Leor, J; Matetzky, S; Novikov, I | 1 |
| Albertini, F; Archetti, S; Assanelli, D; Bonanome, A; Grassi, M; Maccalli, P; Negrini, R; Pezzini, A; Visioli, F | 1 |
| Chen, ZK; Ge, CJ; Hu, SJ | 1 |
| Algra, A; Bloemenkamp, DG; Blom, HJ; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
| Chambless, LE; Howard, VJ; Malinow, MR; Pettigrew, LC; Sides, EG; Spence, JD; Stampfer, M; Toole, JF; Wang, CH | 1 |
| Bengtsson, C; Björkelund, C; Landaas, S; Lissner, L; Sundh, V; Thelle, D; Zylberstein, DE | 1 |
| Karpiński, M; Kiryłów, E; Kosior, J; Kubik, L; Orski, Z; Parol, G; Pecak, R | 1 |
| Amowitz, LL; Komaroff, AL; Loughrey, CM; Ridker, PM; Rifai, N | 1 |
| Delcán, JL; Guerrero, JE; Medina, J; Merino, E; Rodríguez Rodrigo, FJ; Velásquez, E | 1 |
| Kowalska, I; Lewczuk, A; Mroczko, B; Musiał, W; Prokop, J; Sawicki, R; Skibińska, E | 1 |
| Saleheen, D | 1 |
| Frick, B; Fuchs, D; Schroecksnadel, K | 1 |
| Nishio, I; Tsuda, K | 1 |
| Grundt, H; Hetland, Ø; Mansoor, MA; Nilsen, DW | 1 |
| Allen, R; Anand, K; Boden-Albala, B; Lee, HS; Paik, MC; Sacco, RL; Stabler, S | 1 |
| Aamir, M; Anwar, M; Dawood, MM; Dilawar, M; Ijaz, A; Sattar, A | 1 |
| Ghosh, K; Khare, A; Kulkarni, B; Mohanty, D; Shetty, S | 1 |
| Haynes, WG; Lentz, SR | 1 |
| Curhan, G; Hankinson, SE; Ma, J; Manson, JE; Rifai, N; Rimm, EB; Shai, I; Stampfer, MJ | 1 |
| Hallmans, G; Hultdin, J; Jansson, JH; Nilsson, TK; Thøgersen, AM; Weinehall, L | 1 |
| Battaglia, G; Garozzo, M; Milone, F; Urso, S | 1 |
| Darioli, R; Mathez, Ch; Trueb, L; Waeber, G | 1 |
| Crossey, M; Glew, RH; Okolie, H; Pereyra, M; Suberu, O; Trujillo, M; Vanderjagt, DJ | 1 |
| Frossard, P; Saleheen, D | 1 |
| Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Sanchis, J | 1 |
| Alam, MK; Arslan, MI; Banu, S; Hamid, MA; Mollah, FH; Rahman, MA; Wahab, MA | 1 |
| Cieslinski, A; Jakubowski, H; Lacinski, M; Skorupski, W; Sokolowska, J; Trzeciak, WH | 1 |
| Karadede, A; Sucu, MM; Toprak, G; Toprak, NA | 1 |
| D'Almeida, V; Dabela, ML; Fonseca, FA; Helfenstein, T; Izar, MC; Matheus, SC; Relvas, WG; Rodrigues, PR; Santos, AO; Sousa, EF; Souza, FG; Taglieri, R; Tufik, S | 1 |
| Bodi, V; Chorro, FJ; Fácila, L; G, VB; Llacer, A; Nuñez, JE; Sanchis, J | 1 |
| Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Ruiz, V; Sanchis, J | 1 |
| Ascaso, JF; Carmena, R; Chaves, FJ; Gómez, JL; Merchante, A; Real, JT | 1 |
| Chang, HW; Chen, CJ; Chua, S; Hang, CL; Wu, CJ; Yang, CH; Yip, HK | 1 |
| Bertoncelli, P; Bonetti, L; Mattioli, AV; Mattioli, G; Zennaro, M | 1 |
| Bukia, T; Chaava, M; Gogokhia, N | 1 |
| Ahmed, SI; Salahuddin, MI | 1 |
| Assmann, G; Cullen, P; Schulte, H | 1 |
| Albertini, F; Archetti, S; Assanelli, D; Galeazzi, G; Grassi, M; Mozzini, C; Negrini, R; Pezzini, A; Salvadori, G | 1 |
| Davey Smith, G; Ebrahim, S; Lewis, SJ | 1 |
| Gao, QP; Jin, H; Li, SJ; Li, WM; Mei, YF; Wang, LF; Zhou, LJ | 1 |
| Chiariello, M; De Luca, G; Gregorio, G; Lange, H; Suryapranata, H | 1 |
| Rafflenbeul, W | 1 |
| Loscalzo, J | 1 |
| Cummings, DM; Geesey, ME; King, DE; Mainous, AG | 1 |
| Armstrong, KA; Isbel, NM; Johnson, DW; Leano, R; Marwick, TH; Rakhit, DJ | 1 |
| Lewington, S; Lowe, GD; Morrison, CE; Rumley, A; Rumley, C; Woodward, M | 1 |
| Bukiia, TSh; Chaava, MM; Gogokhia, NA | 1 |
| Huber, K; Jordanova, N; Maurer, G; Niessner, A; Nikfardjam, M; Schreiber, W; Speidl, WS; Wojta, J; Zeiner, A; Zorn, G | 1 |
| Iqbal, MP | 1 |
| Brodin, E; Børvik, T; Hansen, JB; Sveinbjørnsson, B; Vik, A | 1 |
| Enli, Y; Evrengul, H; Kaftan, A; Kilic, M; Kuru, O; Seleci, D; Tanriverdi, H; Tanriverdi, S | 1 |
| Heinzl, S | 1 |
| Erzen, B; Keber, I; Poredos, P; Sabovic, M; Sebestjen, M; Simcic, S; Zegura, B | 1 |
| Behar, S; Boyko, V; Brunner, D; Doolman, R; Goldbourt, U; Haim, M; Sela, BA; Tanne, D | 1 |
| Spence, JD | 2 |
| Ghosh, K | 1 |
| Abdella, NA; Al Humood, S; Al Wazzan, H; Marouf, R; Mojiminiyi, OA; Qurtom, M; Zubaid, M | 1 |
| Pietrzik, K | 1 |
| Cottin, Y; Duvillard, L; Gambert, P; Guilland, JC; Korandji, C; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M | 1 |
| Alberca, I; Cruz-González, I; González-Porras, JR; Jimenez-Candil, J; Martín-Herrero, F; Martín-Luengo, C; Martín-Moreiras, J; Moríñigo-Muñoz, JL; Pabón, P; Sánchez, PL | 1 |
| Almeida, OP; Flicker, L; Hankey, GJ; Jamrozik, K; Norman, P; van Bockxmeer, FM; Vasikaran, S | 1 |
| Głuszek, J; Pawlak, AL; Strauss, E; Supiński, W | 1 |
| Claeys, MJ; Goovaerts, I; Moens, AL; Van Hertbruggen, E; Van Hoof, VO; Vrints, CJ; Wendelen, LC; Wuyts, FL | 1 |
| Glowacki, R; Kolarz, M; Kopec, G; Placzkiewicz-Jankowska, E; Tracz, W; Undas, A | 1 |
| Mair, J | 1 |
| Aarsetøy, H; Grundt, H; Mansoor, MA; Nilsen, DW; Reine, A; Valente, E | 1 |
| Angeline, T; Jeyaraj, N; Tsongalis, GJ | 1 |
| Boeing, H; Dierkes, J; Klipstein-Grobusch, K; Luley, C; Möhlig, M; Spranger, J; Weikert, C; Westphal, S | 1 |
| Armitage, J; Bowman, L; Bulbulia, R; Collins, R; Parish, S | 1 |
| Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
| Bang, H; Chambless, LE; Howard, VJ; Pettigrew, LC; Toole, JF | 1 |
| Archetti, S; Assanelli, D; Grassi, M; Kisialiou, A; Mozzini, C; Pezzini, A | 1 |
| Ortega, E; Osorio, A; Ruiz-Requena, E | 1 |
| Gialeraki, A; Komporozos, C; Kremastinos, DT; Lekakis, I; Pavlakis, G; Rallidis, LS; Travlou, A; Vavoulis, P | 1 |
| Bengtsson, C; Björkelund, C; Fogarty, J; Graham, I; Leong, T; Lissner, L; Thelle, D; Ward, D; Zylberstein, D | 1 |
| Dippel, EJ; Harb, H; Jerin, M; Kapalis, M; Reddy, M; Shammas, NW; Toth, PP | 1 |
| Imasa, MS; Nevado, JB | 1 |
| Akarbayram, N; Akçay, M; Bozkurt, E; Durmaz, T; Keleş, T; Ozdemir, L; Yeter, E; Yüksel, I | 1 |
| Berliner, S; Kesler, A; Rogowski, O; Salomon, O; Sela, BA; Shainberg, B; Shalev, V; Shapira, I; Shimron, O | 1 |
| Gupta, VJ; Reddy, SG; Wilcken, DE | 1 |
| Feinleib, M; Havlik, R; Levy, HL; McKusick, VA; Mudd, SH | 1 |
| Adão, M; Azinheira, J; Bordalo e Sá, AL; Ferreira, NC; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L; Vilaverde, MM | 1 |
| Andersson, A; Brattström, L; Hultberg, B; Israelsson, B; Landgren, F; Lindgren, A | 1 |
| Alfthan, G; Ehnholm, C; Jauhiainen, M; Karvonen, M; Pekkanen, J; Pitkäniemi, J; Salonen, JT; Tuomilehto, J | 1 |
| Malinow, MR; Stampfer, MJ | 1 |
| Adão, M; Azinheira, J; Bordalo e Sá, A; Ferreira, NC; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L; Vilaverde, MM | 1 |
| Parhofer, K; Schwandt, P | 1 |
| Arnesen, E; Bønaa, KH; Førde, OH; Nordrehaug, JE; Refsum, H; Ueland, PM | 1 |
| Ellis, JM; McCully, KS | 1 |
| Tsai, MY | 1 |
| Allen, RH; Buring, JE; Gaziano, JM; Hennekens, CH; Kok, FJ; Reynolds, RD; Stabler, SP; Stampfer, MJ; Verhoef, P; Willett, WC | 1 |
| Crooks, R; Dudman, N; Egerton, W; Ray, C; Silberberg, J; Xie, L | 1 |
| Chasan-Taber, L; Hennekens, CH; Malinow, MR; Rosenberg, IH; Selhub, J; Stampfer, MJ; Terry, P; Tishler, PV; Willett, W | 1 |
| Graham, IM; Meleady, RA; Mulcahy, DA | 1 |
| Buring, J; Gaziano, JM; Lindpaintner, K; Schmitz, C; Verhoef, P | 1 |
| Arveiler, D; Cambien, F; Ducimetiere, P; Evans, AE; Luc, G; Malinow, MR; Upson, BM | 1 |
| Frosst, P; Hennekens, CH; Horsford, J; Ma, J; Malinow, MR; Rozen, R; Selhub, J; Stampfer, MJ; Willett, WC | 1 |
| Graham, I; Meleady, R | 1 |
| Anker, G; Lien, EA; Lønning, PE; Refsum, H; Ueland, PM | 1 |
| Domagała, TB; Gozdecka, H; Krzanowski, M; Libura, M; Szczeklik, A | 1 |
| Boxer, LM; Ciesielski-Carlucci, C; Lee, BK; Leung, LL | 1 |
| Beverly, RK; Hess, DL; Koepsell, TD; Longstreth, WT; Malinow, MR; Psaty, BM; Raghunathan, TE; Reitsma, PH; Rosendaal, FR; Schwartz, SM; Siscovick, DS | 1 |
| Bots, ML; Grobbee, DE; Hofman, A; Launer, LJ; Lindemans, J | 1 |
| Hopkins, PN; Hunt, SC; James, BC; Vincent, GM; Williams, RR; Wu, LL | 1 |
| Alasmi, M; Fontaine, RN; Glueck, CJ; Gupta, A | 1 |
| Bowron, A; Gudnason, V; Humphries, S; Nicaud, V; Scott, J; Stansbie, D | 1 |
| Baglietto, L; Bettega, D; Cattaneo, M; Costa, A; Decensi, A; Mannucci, PM; Robertson, C; Zighetti, ML | 1 |
| Ali, A; Lavie, CJ; Li, S; Lin, HC; Lohmann, TP; Malik, FS; Mehra, MR; Milani, RV; Murgo, JP | 1 |
| Bots, ML; Grobbee, DE; Hoes, AW; Hofman, A; Koudstaal, PJ; Launer, LJ; Lindemans, J; Witteman, JC | 1 |
| Cowley, G | 1 |
| Assanelli, D; Bersatti, F; Bollani, G; Cattaneo, M; Ferrari, M; Ferrari, R; Visioli, O; Zighetti, ML | 1 |
| Gardemann, A; Haberbosch, W; Hehrlein, FW; Katz, N; Philipp, M; Tillmanns, H; Weidemann, H | 1 |
| Buring, JE; Hennekens, CH; Manson, JE; Matias, M; Ridker, PM; Shih, J | 1 |
| Titus, K | 1 |
| Mendis, S | 1 |
| Ridker, PM | 2 |
| Ebrahim, SB; Lennon, L; Morris, R; Perry, IJ; Refsum, H; Thomson, A; Ueland, PM; Walker, M; Whincup, PH | 1 |
| Auer, J; Eber, B | 1 |
| Berg, K; Christensen, B; Djurovic, S; Landaas, S; Retterstøl, L; Ringstad, J; Stensvold, I; Thelle, DS | 1 |
| Lenhart, SE; Nappi, JM | 1 |
| Kircher, T; Sinzinger, H | 1 |
| Dudman, NP | 1 |
| Adami, A; Al-Obaidi, MK; Amersey, R; Lane, DA; Noble, MM; Philippou, H; Stubbs, PJ | 1 |
| Croft, JB; Ford, ES; Giles, WH; Greenlund, KJ; Kittner, SJ | 1 |
| Fusazaki, T; Hiramori, K; Ishida, T; Itoh, C; Kamata, J; Kawazoe, K; Nakai, K; Ogiu, N; Ohsawa, M; Suzuki, T; Yanagisawa, M | 1 |
| Apakkan, S; Bayindir, O; Boydak, B; Habif, S; Mutaf, I; Ozmen, D; Turgan, N | 1 |
| Cooke, GE; Goldschmidt-Clermont, PJ; Moeschberger, ML; Qiu, P | 1 |
| Bolander-Gouaille, C | 1 |
| Adão, M; Azinheira, J; Bordalo e Sá, A; Correia, JM; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, AL; Tavares, J | 1 |
| Bleich, S; Degner, D | 1 |
| Ahn, C; Aronow, WS | 1 |
| Al-Obaidi, MK; Collinson, PO; Conroy, RM; Graham, IM; Noble, IM; Stubbs, PJ | 1 |
| Griffiths, J; Nagendran, J; Senaratne, MP | 1 |
| Anand, S | 1 |
| Al-Obaidi, MK; Collinson, P; Conroy, R; Graham, I; Noble, MI; Stubbs, PJ | 1 |
| Gao, W; Jiang, N; Zhu, G | 1 |
| Bridge, PJ; Fick, G; Hyndman, ME; Parsons, HG; Warnica, JW | 1 |
| Arcelus, R; Blanco-Vaca, F; Camps, J; Figuera, L; Joven, J; Martorell, L; Simó, JM; Vilella, E; Virgos, C | 1 |
| Clayton, A; Cummings, CE; Kirkpatrick, C; Kush, D; Liu, M; MacMahon, M; Robinson, PJ; Tobert, J; Tomiak, RH | 1 |
| Crook, D; Godsland, IF; Lidegaard, O; Winkler, U | 1 |
| Frohlich, JJ; Gasparovic, J; Raslová, K; Smolková, B; Vohnout, B | 1 |
| Al-Obaidi, MK; Amersey, R; Noble, MI; Stubbs, PJ | 1 |
| Chen, J; Hennekens, CH; Hunter, DJ; Ma, J; Malinow, MR; Selhub, J; Stampfer, MJ | 1 |
| Boman, K; Dahlen, G; Hallmans, G; Huhtasaari, F; Jansson, JH; Nilsson, TK; Thögersen, AM | 1 |
| Akar, E; Akar, N; Aras, O; Avci, F; Dinçer, I; Gülec, S; Omürlü, K; Oral, D; Tutar, E | 1 |
| Hosini, L; Omran, TS; Qujeq, D | 1 |
| Axenti, I; Brzostek, T; Czachór, R; Dropiński, J; Jankowski, M; Musiał, J; Sanak, M; Szczeklik, A; Tendera, M; Twardowska, M | 1 |
| Bogaty, P; Boyer, L; Dagenais, GR; Poirier, P; Simard, S; Solymoss, S | 1 |
| Abbate, R; Brunelli, T; Fedi, S; Gensini, GF; Giusti, B; Marcucci, R; Pepe, G; Poli, D; Prisco, D | 1 |
| Alho, H; Jokela, H; Kalela, A; Koivu, TA; Koivula, T; Nikkari, ST; Sillanaukee, P | 1 |
| Graf, S; Hornykewycz, S; Huber, K; Huber-Beckmann, R; Nikfardjam, M; Wojta, J; Zorn, G | 1 |
| Arosio, E; Guidi, G; Lippi, G; Prior, M | 1 |
| Dai, C; Zhang, G | 1 |
| Barlera, S; Chiodini, BD; Franzosi, MG; Tognoni, G | 1 |
| Barini, A; Bastagli, L; Boni, P; Cappelletti, O; Drago, G; Legnani, C; Mele, MC; Muscari, A; Poggiopollini, G; Puddu, P; Tomassetti, V | 1 |
| Clearfield, M; Cook, TJ; Downs, JR; Gotto, AM; Pradhan, AD; Ridker, PM; Shih, J; Weis, SE | 1 |
| Dambinova, SA; Khounteev, GA; Skoromets, AA | 1 |
| Green, R; Jagust, WJ; Miller, JW; Mungas, DM; Reed, BR | 1 |
| Jacques, PF; Kark, JD; Rosenberg, IH; Selhub, J; Sinnreich, R | 1 |
| Hennekens, CH; Malinow, MR; Newcomer, LM; Stampfer, MJ; Tishler, PV; Ullmann, D; Upson, B; Willett, WC | 1 |
| Dudman, NP; Lynch, J; Wang, J; Wilcken, DE | 1 |
| Andersson, A; Brattström, L; Hultberg, B; Isaksson, A; Israelsson, B | 1 |
| McCully, KS; Olszewski, AJ; Szostak, WB | 1 |
| Olszewski, AJ; Szostak, WB | 1 |
| McCully, KS; Vezeridis, MP | 1 |
23 review(s) available for homocysteine and Cardiovascular Stroke
| Article | Year |
|---|---|
Homocysteine, Vitamins B6 and Folic Acid in Experimental Models of Myocardial Infarction and Heart Failure-How Strong Is That Link?
Topics: Animals; Folic Acid; Gasotransmitters; Heart Failure; Homocysteine; Hyperhomocysteinemia; Inflammation; Models, Theoretical; Myocardial Infarction; Vitamin B 6; Vitamins | 2022 |
Homocysteine levels in patients with coronary slow flow phenomenon: A meta-analysis.
Topics: Coronary Angiography; Homocysteine; Humans; Myocardial Infarction; No-Reflow Phenomenon | 2023 |
No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study.
Topics: Coronary Artery Disease; Genome-Wide Association Study; Homocysteine; Humans; Mendelian Randomization Analysis; Myocardial Infarction; Polymorphism, Single Nucleotide | 2021 |
The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism.
Topics: Aged; Angina, Unstable; Biomarkers; Case-Control Studies; Coronary Disease; Female; Genotype; Heterozygote; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors | 2013 |
[Hyperhomocysteinemia in patients with cardiovascular disease].
Topics: Cardiovascular Diseases; Causality; Comorbidity; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Myocardial Infarction; Risk Factors; Vitamin B 12 | 2014 |
Interventions for lowering plasma homocysteine levels in dialysis patients.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Stroke; Venous Thrombosis; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2016 |
Is folic acid supplementation useful for chronic kidney disease?
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Renal Insufficiency, Chronic; Risk Factors; Stroke | 2016 |
Alterations in homocysteine metabolism among alcohol dependent patients--clinical, pathobiochemical and genetic aspects.
Topics: Alcohol Withdrawal Seizures; Alcoholism; Alleles; DNA Methylation; Dopamine; Epigenesis, Genetic; Ethanol; Folic Acid; Gene Expression Regulation, Enzymologic; Homocysteine; Humans; Methylenetetrahydrofolate Dehydrogenase (NADP); Myocardial Infarction; Polymorphism, Single Nucleotide; Receptors, N-Methyl-D-Aspartate; Reward; Risk Factors; Social Environment; Vitamin B 12; Vitamin B 6 | 2008 |
Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.
Topics: Capsules; Double-Blind Method; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Patient Compliance; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2010 |
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
Topics: Coronary Disease; Databases, Factual; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin B Complex | 2012 |
[The relationship of cystatin C and cardiovascular diseases].
Topics: Animals; Arteriosclerosis; Cystatin C; Cystatins; Cysteine Proteinase Inhibitors; Homocysteine; Humans; Myocardial Infarction | 2003 |
Homocysteine: is it a clinically important cardiovascular risk factor?
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Myocardial Infarction; Reference Values; Risk Factors; Vitamin B Complex | 2004 |
Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?
Topics: Case-Control Studies; Coronary Stenosis; Folic Acid; Genotype; Global Health; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Polymorphism, Genetic; Prospective Studies; Residence Characteristics | 2005 |
[Homocysteine--risk factor or risk indicator?].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Child; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin B Complex | 2005 |
Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Homocystinuria; Humans; Kidney Diseases; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Vitamin B Complex | 2006 |
[Biomarkers in cardiology--state of the art 2007].
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Heart Diseases; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin | 2007 |
Homocysteine-lowering therapy: a role in stroke prevention?
Topics: Animals; Clinical Trials as Topic; Homocysteine; Humans; Myocardial Infarction; Risk; Stroke; Vitamin B 12; Vitamin B 6 | 2007 |
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Coronary Disease; Estrogen Antagonists; Female; Homocysteine; Humans; Male; Myocardial Infarction; Tamoxifen | 1997 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?
Topics: Biomarkers; C-Reactive Protein; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Reproducibility of Results; Risk Factors; Tissue Plasminogen Activator | 1999 |
Vitamins for the management of cardiovascular disease: a simple solution to a complex problem?
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Myocardial Infarction; Vitamin B Complex; Vitamin E; Vitamins | 1999 |
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.
Topics: Adult; Carbohydrate Metabolism; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Synthetic; Female; Homocysteine; Humans; Incidence; Lipid Metabolism; Myocardial Infarction; Risk Factors; Stroke; Structure-Activity Relationship; Thromboembolism | 2000 |
[Susceptibility gene to infarct: a review of the literature].
Topics: Case-Control Studies; Genetic Predisposition to Disease; Hemostasis; Homocysteine; Humans; Lipid Metabolism; Myocardial Infarction; Renin-Angiotensin System | 2001 |
23 trial(s) available for homocysteine and Cardiovascular Stroke
| Article | Year |
|---|---|
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
Topics: Coronary Artery Disease; Fibrin; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Prognosis; Risk Factors; Thrombosis; Vitamin B 12; Vitamin B Complex | 2022 |
The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.
Topics: Adult; Aged; Brain Ischemia; China; Double-Blind Method; Folic Acid; Homocysteine; Humans; Intracranial Hemorrhage, Hypertensive; Middle Aged; Myocardial Infarction; Protective Agents; Research Design; Secondary Prevention; Stroke; Vitamin B 12; Vitamin B 6 | 2015 |
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
Topics: Aged; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Morbidity; Myocardial Infarction; Treatment Outcome; Vitamin B 12; Vitamin B Complex | 2010 |
Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial.
Topics: Aged; Anesthetics, Inhalation; Biomarkers; Cause of Death; Chi-Square Distribution; Female; Follow-Up Studies; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Nitrous Oxide; Odds Ratio; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke; Surgical Procedures, Operative; Survival Rate; Time Factors; Treatment Outcome | 2011 |
The association between homocysteine level and metabolic syndrome in patients of prior myocardial infarction.
Topics: Age Factors; Aged; Blood Glucose; Coronary Angiography; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Sex Factors | 2010 |
Utility of Framingham Coronary Heart Disease Risk Score for predicting cardiac risk after stroke.
Topics: Adult; Coronary Disease; Double-Blind Method; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Vitamins | 2012 |
Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients.
Topics: Adult; Antioxidants; Diagnostic Techniques and Procedures; Dietary Supplements; Drug Administration Schedule; Endothelium, Vascular; Female; Folic Acid; Gene Frequency; Genetic Markers; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Pharmacology, Clinical; Uric Acid; Vasodilation; Vitamin E | 2004 |
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Topics: Adult; Aged; Coronary Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2004 |
Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Corn Oil; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Female; Follow-Up Studies; Homocysteine; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Prognosis; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Triglycerides | 2004 |
[The effect of homocysteine on fibrinolytic system in human umbilical vein endothelial cells].
Topics: Aged; Case-Control Studies; Cells, Cultured; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins | 2005 |
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.
Topics: Coronary Disease; Death, Sudden, Cardiac; Disease-Free Survival; Echocardiography, Stress; Female; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Regression Analysis; Renal Dialysis; Risk Factors; Secondary Prevention | 2006 |
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Topics: Adult; Aged; Coronary Artery Disease; Female; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tissue Plasminogen Activator | 2007 |
Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
Topics: Bezafibrate; Case-Control Studies; Coronary Disease; Death, Sudden, Cardiac; Female; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors | 2007 |
Effect of folic acid on endothelial function following acute myocardial infarction.
Topics: Brachial Artery; Chi-Square Distribution; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Treatment Outcome; Vitamin B Complex | 2007 |
Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol; Dose-Response Relationship, Drug; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Simvastatin; Survival Rate; Time Factors; Treatment Outcome; United Kingdom; Vitamin B 12; Vitamin B Complex | 2007 |
Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Risk; Stroke; Vitamins | 2008 |
Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid.
Topics: Adult; Aged; Aged, 80 and over; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 1995 |
Tamoxifen reduces plasma homocysteine levels in healthy women.
Topics: Adult; Aged; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Female; Homocysteine; Humans; Hysterectomy; Middle Aged; Myocardial Infarction; Placebos; Risk Factors; Tamoxifen | 1998 |
The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease.
Topics: Adult; Aged; Analysis of Variance; Coronary Artery Disease; Genetic Markers; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prognosis; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index | 1999 |
Homocysteine and fibrinolysis in acute occlusive coronary events.
Topics: Adult; Aged; Aged, 80 and over; Fibrinolytic Agents; Homocysteine; Humans; Middle Aged; Myocardial Infarction | 1999 |
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH).
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Folic Acid; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Placebos; Simvastatin; Triglycerides; Vitamin B 12 | 2000 |
Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Double-Blind Method; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prospective Studies | 2001 |
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
Topics: Acute Disease; Aged; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2002 |
221 other study(ies) available for homocysteine and Cardiovascular Stroke
| Article | Year |
|---|---|
Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.
Topics: Angina, Unstable; Cholesterol, HDL; Coronary Artery Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homer Scaffolding Proteins; Homocysteine; Humans; Hypertension; Myocardial Infarction; Retrospective Studies | 2022 |
Association of Homocysteine and Risks of Long-Term Cardiovascular Events and All-Cause Death among Older Patients with Obstructive Sleep Apnea: A Prospective Study.
Topics: Aged; Female; Homocysteine; Humans; Male; Myocardial Infarction; Prospective Studies; Risk Factors; Sleep Apnea, Obstructive | 2022 |
MTHFR C677T polymorphism, homocysteine, burden, and location of AMI and ACI.
Topics: Brain Ischemia; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Stroke | 2023 |
Serum homocysteine relates to elevated lipid level, inflammation and major adverse cardiac event risk in acute myocardial infarction patients.
Topics: Angina Pectoris; Biomarkers; Cholesterol, LDL; Homocysteine; Humans; Inflammation; Myocardial Infarction | 2023 |
Sensitively detecting endogenous homocysteine in human serum and cardiomyocytes with a specific fluorescent probe.
Topics: Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Homocysteine; Humans; Myocardial Infarction; Myocytes, Cardiac; Spectrometry, Fluorescence | 2023 |
High-resolution metabolomics study revealing l-homocysteine sulfinic acid, cysteic acid, and carnitine as novel biomarkers for high acute myocardial infarction risk.
Topics: Aged; Amino Acids; Biomarkers; Carnitine; Cohort Studies; Cysteic Acid; Female; Homocysteine; Humans; Least-Squares Analysis; Male; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Assessment; Risk Factors | 2020 |
Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway.
Topics: Animals; Cell Survival; Cells, Cultured; Chromones; Endothelial Cells; Homocysteine; Humans; Hyperhomocysteinemia; Hypoxia; Male; Mice; Microcirculation; Morpholines; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nicorandil; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Plant Lectins; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Ventricular Function, Left | 2020 |
Translocator Protein Modulation by 4'-Chlorodiazepam and NO Synthase Inhibition Affect Cardiac Oxidative Stress, Cardiometabolic and Inflammatory Markers in Isoprenaline-Induced Rat Myocardial Infarction.
Topics: Animals; Benzodiazepinones; Biomarkers; Carrier Proteins; Enzyme Inhibitors; Glutathione Peroxidase; Homocysteine; Isoproterenol; Male; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Rats, Wistar; Receptors, GABA-A; Superoxide Dismutase; Troponin T; Tumor Necrosis Factor-alpha | 2021 |
Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk.
Topics: Acute Coronary Syndrome; Age Factors; Age of Onset; Biomarkers; Body Mass Index; Female; Follow-Up Studies; Heart Disease Risk Factors; Homocysteine; Humans; Hypertension; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Retrospective Studies; Risk Assessment | 2021 |
Polymorphisms in MTHFR, MS and CBS genes and premature acute myocardial infarction in a Pakistani population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adolescent; Adult; Age of Onset; Analysis of Variance; Biomarkers; Case-Control Studies; Chi-Square Distribution; Cross-Sectional Studies; Cystathionine beta-Synthase; Female; Genetic Association Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Pakistan; Phenotype; Polymorphism, Single Nucleotide; Prevalence; Risk Factors; Up-Regulation; Young Adult | 2016 |
Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons.
Topics: Adolescent; Adult; Blood Coagulation; DNA; Factor XIIIa; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genotype; Homocysteine; Humans; Male; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
Topics: Aged; Angina, Stable; Biomarkers; C-Reactive Protein; Coronary Angiography; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation Mediators; Kaplan-Meier Estimate; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Neopterin; Norway; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Up-Regulation | 2017 |
Hyperuricemia is associated with short-term outcomes in elderly patients with acute myocardial infarction.
Topics: Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Female; Homocysteine; Humans; Hyperuricemia; Incidence; Logistic Models; Male; Middle Aged; Myocardial Infarction; Risk Factors; Triglycerides | 2018 |
Prognostic ability of cystatin C and homocysteine plasma levels for long-term outcomes in very old acute myocardial infarction patients.
Topics: Aged; Angina, Unstable; Biomarkers; China; Coronary Angiography; Cystatin C; Disease-Free Survival; Female; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Prognosis; Proportional Hazards Models; Risk Factors; Sensitivity and Specificity | 2018 |
The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A.
Topics: Angina, Stable; Biomarkers; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Vitamin A | 2018 |
A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Lymphocytes; Male; Middle Aged; Myocardial Infarction; Neutrophils; Percutaneous Coronary Intervention; Uric Acid | 2018 |
Serum vitamin A, total homocysteine and acute myocardial infarction: is there a causal association?
Topics: Diagnostic Tests, Routine; Homocysteine; Humans; Myocardial Infarction; Plasma; Vitamin A | 2018 |
Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: A STROBE-compliant observational study.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Biomarkers; Body Mass Index; Comorbidity; Female; Health Status Indicators; Hematologic Tests; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; ROC Curve | 2018 |
High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; China; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Stroke | 2019 |
Relationship between serum homocysteine levels and long-term outcomes in patients with ST-segment elevation myocardial infarction.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Female; Homocysteine; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; ST Elevation Myocardial Infarction | 2019 |
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Stroke; Vitamin B Complex | 2013 |
Low erythrocyte catalase enzyme activity is correlated with high serum total homocysteine levels in Tunisian patients with acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Antioxidants; Catalase; Erythrocytes; Female; Homocysteine; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Tunisia | 2013 |
Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and enhances diastolic function after myocardial infarction in mice.
Topics: Adenoviridae; Animals; Cystathionine beta-Synthase; Diastole; Diet, High-Fat; Female; Genetic Vectors; Heart; Heart Failure; Homocysteine; Homocystinuria; Hypercholesterolemia; Hyperhomocysteinemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Receptors, LDL; Transgenes; Ventricular Remodeling | 2013 |
Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Female; Folic Acid; Genetic Association Studies; Genetics, Population; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Vitamin B 12 | 2013 |
B-vitamins intake, DNA-methylation of One Carbon Metabolism and homocysteine pathway genes and myocardial infarction risk: the EPICOR study.
Topics: Adult; Aminomethyltransferase; Aryldialkylphosphatase; Case-Control Studies; DNA Methylation; Female; Follow-Up Studies; Homocysteine; Humans; Logistic Models; Male; Metabolic Networks and Pathways; Middle Aged; Multivariate Analysis; Myocardial Infarction; Promoter Regions, Genetic; Prospective Studies; Risk Factors; Transcobalamins; Vitamin B Complex | 2014 |
Correlation between balloon release pressure and no-reflow in patients with acute myocardial infarction undergoing direct percutaneous coronary intervention.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention | 2014 |
Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
Topics: Aged; Aged, 80 and over; Biomarkers; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Factors; Stents | 2015 |
Hyperhomocysteinemia-induced myocardial infarction in a young male using anabolic steroids.
Topics: Adult; Anabolic Agents; Electrocardiography; Emergency Service, Hospital; Homocysteine; Humans; Hyperhomocysteinemia; Male; Myocardial Infarction | 2014 |
Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Vitamin B 12; Vitamins | 2014 |
Genetic polymorphisms, Biochemical Factors, and Conventional Risk Factors in Young and Elderly North Indian Patients With Acute Myocardial Infarction.
Topics: Adult; Aged; Antigens, Human Platelet; Blood Coagulation Factors; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Obesity; Polymorphism, Genetic; Risk Factors | 2016 |
Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Linear Models; Male; Myocardial Infarction; Risk Assessment; Risk Factors; Vitamin B 12 | 2014 |
Acute Myocardial Infarction in a Young Man with Hyperhomocysteinemia and Pulmonary Tuberculosis.
Topics: Acute Disease; Adult; Chest Pain; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Factors; Tuberculosis, Pulmonary; Vitamin B Complex | 2016 |
Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Area Under Curve; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Artery Disease; Cystathionine beta-Synthase; Disease Progression; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Homocysteine; Homozygote; Humans; Kaplan-Meier Estimate; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; ROC Curve; Stroke; Time Factors | 2017 |
Diagnostic value of joint detection of homocysteine and RDW CV on acute myocardial infarction. Retracted.
Topics: Aged; Coronary Artery Disease; Erythrocyte Indices; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Sensitivity and Specificity | 2016 |
Homocysteine-reducing B vitamins and ischemic heart disease: a separate-sample Mendelian randomization analysis.
Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Vitamin B 12; Vitamin B Complex | 2017 |
Serum Klotho (but not haplotypes) associate with the post-myocardial infarction status of older adults.
Topics: Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Anthropometry; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Energy Intake; Enzyme-Linked Immunosorbent Assay; Female; Genotyping Techniques; Glucuronidase; Haplotypes; Homocysteine; Humans; Klotho Proteins; Male; Middle Aged; Myocardial Infarction; Nutrition Assessment; Reference Values; Risk Factors; Sex Factors; Statistics, Nonparametric; Stroke | 2016 |
Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Chromatography, High Pressure Liquid; Female; Homocysteine; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke | 2008 |
Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Female; Folic Acid; Gene Frequency; Genotype; Homocysteine; Humans; Male; Middle Aged; Mutation; Myocardial Infarction; Tunisia; Vitamin B 12 | 2008 |
Homocysteine: the Rubik's cube of cardiovascular risk factors.
Topics: Atherosclerosis; Biomarkers; Coronary Disease; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Inflammation Mediators; Myocardial Infarction; Platelet Activation; Research Design; Risk Assessment; Risk Factors; Smoking; Stroke; Vascular Cell Adhesion Molecule-1; Vitamin B Complex | 2008 |
Plasma homocysteine level and left ventricular thrombus formation in acute anterior myocardial infarction patients following thrombolytic therapy with t-PA.
Topics: Adult; Echocardiography; Fasting; Female; Fibrinolytic Agents; Heart Ventricles; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Ventricular Dysfunction, Left | 2009 |
[Vitamin B substitution. No protection for the heart -- but for the brain!].
Topics: Cohort Studies; Controlled Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Meta-Analysis as Topic; Myocardial Infarction; Prospective Studies; Retrospective Studies; Risk Factors; Stroke; Time Factors; Vitamin B 12; Vitamin B 6 | 2008 |
Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Aspartate Aminotransferases; Betaine; Catalase; Creatine Kinase; Glutathione Transferase; Homocysteine; Isoproterenol; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; Spectrophotometry, Ultraviolet; Superoxide Dismutase | 2010 |
Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
Topics: Adult; Aged; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Health Surveys; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prospective Studies; Riboflavin; Risk; Sex Distribution; Sweden; Vitamin B 12; Vitamin B 6 | 2009 |
Changes in serum homocysteine level follow two different trends in patients during early post myocardial infarction period.
Topics: Cholesterol, VLDL; Creatine Kinase, MB Form; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2009 |
Plasma homocysteine level is unrelated to long-term cardiovascular events in patients with previous percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Female; Follow-Up Studies; Homocysteine; Hospitalization; Humans; Male; Myocardial Infarction; Myocardial Revascularization; Recurrence; Time Factors | 2009 |
Plasma vitamin B(6) and risk of myocardial infarction in women.
Topics: Adult; Alcohol Drinking; Body Mass Index; Case-Control Studies; Creatinine; Feeding Behavior; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Middle Aged; Myocardial Infarction; Nutrition Assessment; Prospective Studies; Pyridoxal Phosphate; Risk Factors; Vitamin B 6 | 2009 |
Homocysteine level in Iranian patients with premature acute myocardial infarction.
Topics: Adult; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2009 |
Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: a prospective study.
Topics: Adult; Case-Control Studies; Cysteine; Female; Homocysteine; Humans; Middle Aged; Myocardial Infarction; Risk Factors | 2010 |
Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in mice.
Topics: Animals; Dietary Supplements; Folic Acid; Heart; Hematinics; Homocysteine; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Models, Animal; Myocardial Infarction; Myocytes, Cardiac; Neovascularization, Physiologic; Tissue Inhibitor of Metalloproteinases; Treatment Outcome; Ventricular Function, Left | 2010 |
Relation of homocysteine levels with patency and flow rate of infarct-related artery in patients receiving fibrinolytic therapy.
Topics: Biomarkers; Blood Flow Velocity; Chest Pain; Chromatography, High Pressure Liquid; Coronary Angiography; Fibrinolytic Agents; Homocysteine; Humans; Myocardial Infarction; Patient Selection; Regression Analysis | 2010 |
When the patient asks. Can folic acid lower heart attack risk?
Topics: Dietary Supplements; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Risk Reduction Behavior | 2010 |
The plasma homocysteine concentrations and prior myocardial infarction.
Topics: Aged; Biomarkers; Body Mass Index; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors | 2010 |
The enigma of ENIGMA-I.
Topics: Anesthetics, Inhalation; Biomarkers; Cause of Death; Homocysteine; Humans; Myocardial Infarction; Nitrous Oxide; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Surgical Procedures, Operative; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction.
Topics: Aged; Biomarkers; Chi-Square Distribution; Chronic Disease; Cross-Sectional Studies; Echocardiography, Doppler; Female; Fluorescence Polarization Immunoassay; Heart Failure; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Predictive Value of Tests; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Up-Regulation; Ventricular Function, Left | 2011 |
Hyperhomocysteinemia inhibited cardiac stem cell homing into the peri-infarcted area post myocardial infarction in rats.
Topics: Animals; Animals, Newborn; Blotting, Western; Cell Movement; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Homocysteine; Hyperhomocysteinemia; Immunohistochemistry; Male; Methionine; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Factor; Stem Cells | 2011 |
Serum total homocysteine and lipoprotein (a) levels in acute myocardial infarction and their response to treatment with vitamins.
Topics: Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Vitamin B Complex | 2011 |
Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Prognosis; Retrospective Studies; Time Factors; Triiodobenzoic Acids | 2011 |
Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Topics: Aged; Biomarkers; Comorbidity; Coronary Artery Disease; Female; Homocysteine; Humans; Hungary; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prevalence; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sex Distribution; Statistics as Topic | 2012 |
Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. Homocysteine and congestive heart failure.
Topics: Biomarkers; Chromatography, High Pressure Liquid; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Homocysteine; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Retrospective Studies | 2011 |
Using neural networks to determine the contribution of danshensu to its multiple cardiovascular activities in acute myocardial infarction rats.
Topics: Acute Disease; Algorithms; Animals; Area Under Curve; Cardiovascular Agents; Drugs, Chinese Herbal; Glutathione; Homocysteine; Lactates; Ligation; Male; Myocardial Infarction; Neural Networks, Computer; Phytotherapy; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Troponin T | 2011 |
Low density lipoprotein S-homocysteinylation is increased in acute myocardial infarction patients.
Topics: Acute Coronary Syndrome; Aged; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Cysteine; Electrophoresis, Capillary; Female; Homocysteine; Humans; Italy; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sulfhydryl Compounds | 2012 |
Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction.
Topics: Acute Coronary Syndrome; Adult; Aged; Biomarkers; Cross-Sectional Studies; Female; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Risk Factors; Troponin I; Young Adult | 2012 |
Betaine and secondary events in an acute coronary syndrome cohort.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Betaine; Chromatography, High Pressure Liquid; Cohort Studies; Female; Heart Failure; Homocysteine; Humans; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Myocardial Infarction; New Zealand; Risk Factors; Sarcosine | 2012 |
Association between endothelial nitric oxide gene intron 4a4b VNTR polymorphism and plasma homocysteine concentrations in Tunisian male patients with myocardial infarction.
Topics: Adult; Alleles; Coronary Artery Disease; Endothelium, Vascular; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Introns; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Polymorphism, Genetic; Tunisia | 2012 |
Association between plasma homocysteine and myocardial SPECT abnormalities in patients referred for suspected myocardial ischaemia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Cardiotonic Agents; Chi-Square Distribution; Coronary Artery Disease; Exercise Test; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Predictive Value of Tests; Prospective Studies; Referral and Consultation; Risk Assessment; Risk Factors; Severity of Illness Index; South Africa; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Up-Regulation; Vasodilator Agents; Ventricular Function, Left | 2012 |
Relative importance of risk factors for coronary heart disease--the Hordaland Homocysteine study.
Topics: Adult; Age Factors; Aged; Biomarkers; Chi-Square Distribution; Cholesterol; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Triglycerides | 2012 |
Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
Topics: Arginine; Case-Control Studies; Coronary Angiography; Coronary Circulation; Demography; Female; Hemorheology; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nitric Oxide | 2012 |
Acute myocardial infarction in a young patient with hyperhomocysteinaemia.
Topics: Acute Disease; Adult; Betaine; Coronary Vessels; Folic Acid; Heart; Homocysteine; Humans; Hyperhomocysteinemia; Male; Myocardial Infarction; Myocardium; Thrombosis; Troponin; Ventricular Function, Left | 2012 |
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis.
Topics: Alleles; Aryldialkylphosphatase; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Glutathione; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidative Stress; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Thrombosis | 2013 |
Reply to Fang SK--Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Stroke; Vitamin B Complex | 2013 |
Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Exercise Test; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
Relation of plasma homocysteine levels to intracoronary thrombus in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
Topics: Angina, Unstable; Biomarkers; Coronary Thrombosis; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Statistics as Topic | 2002 |
Homocysteine increase after acute myocardial infarction--can it explain the differences between case-control and cohort studies?
Topics: Biomarkers; Case-Control Studies; Cohort Studies; Fasting; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 2002 |
Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism?
Topics: Adult; Aged; Arteriosclerosis; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypothyroidism; Male; Middle Aged; Myocardial Infarction; Risk Factors; Thyrotropin; Thyroxine | 2002 |
Myocardial infarction in the very young.
Topics: Adolescent; Adult; Aged; Cholesterol, LDL; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2002 |
Myocardial infarction in South Asians.
Topics: Aged; Asia; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Ontario; Risk Factors | 2002 |
Homocysteine, folate and vitamin B12 as risk factors for acute myocardial infarction in a Southeast Asian population.
Topics: Adult; Aged; Asian People; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Logistic Models; Male; Middle Aged; Myocardial Infarction; Risk Factors; Seroepidemiologic Studies; Singapore; Vitamin B 12 | 2002 |
Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques.
Topics: Adult; Analysis of Variance; Coronary Artery Disease; Coronary Thrombosis; Death, Sudden, Cardiac; Diabetes Mellitus; Fibrosis; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors | 2002 |
[Homocysteine and coronary events in coronary disease patients].
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cause of Death; Creatinine; Disease-Free Survival; Female; Follow-Up Studies; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis | 1999 |
Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study.
Topics: Adult; Biomarkers; Cohort Studies; Death, Sudden, Cardiac; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Risk Factors; Survival Analysis | 2003 |
Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction.
Topics: Aged; Aged, 80 and over; Biomarkers; Female; Heart Failure; Homocysteine; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Factors; Ultrasonography | 2003 |
[Hyperhomocysteinemia hastens myocardial infarct and stroke. Prevention.with leaf salads and vitamins].
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Clinical Trials as Topic; Dementia; Diet; Drug Therapy, Combination; Female; Folic Acid; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Male; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Stroke; Vegetables; Vitamin B 12; Vitamin B 6 | 2003 |
Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction.
Topics: Aged; Cardiac Catheterization; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Risk Factors; ROC Curve | 2003 |
Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Female; Folic Acid; Genetic Variation; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Risk Factors; Vitamin B 12 | 2004 |
Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk Factors; Sweden | 2004 |
[Diagnostic and prognostic significance of homocysteine determined in acute phase of myocardial infarction].
Topics: Adult; Aged; Exercise Test; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Ventricular Dysfunction, Left | 2003 |
High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction.
Topics: Adult; Antibodies, Anticardiolipin; beta 2-Glycoprotein I; Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Female; Glycoproteins; Homocysteine; Humans; Massachusetts; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prevalence; Prothrombin; Risk Factors; Serum Amyloid A Protein; Smoking; Surveys and Questionnaires; Vitamin B 12 | 2004 |
[Myocardial infarction and 5,10-methylenetetrahydro-folate reductase mutation].
Topics: Adult; Coronary Angiography; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Myocardial Infarction | 2004 |
Homocysteine and progression of coronary artery disease.
Topics: Adult; Blood Glucose; Coronary Artery Disease; Disease Progression; Folic Acid; Homocysteine; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Obesity; Research Design; Risk Factors; Smoking; Vitamin B 12 | 2004 |
Evaluation of risk factors in young patients with myocardial infarction.
Topics: Homocysteine; Humans; Lipids; Lipoproteins; Myocardial Infarction; Risk Factors | 2004 |
Homocysteine is an independent risk factor for myocardial infarction, in particular fatal myocardial infarction in middle-aged women.
Topics: Causality; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Oxidative Stress; Risk Factors | 2004 |
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Nitric Oxide; Risk; Risk Factors | 2004 |
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.
Topics: Aged; Black People; Cohort Studies; Female; Hispanic or Latino; Homocysteine; Humans; Male; Methylmalonic Acid; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Vascular Diseases; White People | 2004 |
Hyperhomocysteinemia as a risk factor for ischemic heart disease.
Topics: Case-Control Studies; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Risk Factors | 2004 |
Combination of thrombophilia markers in acute myocardial infarction of the young.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Echocardiography; Electrophoresis, Polyacrylamide Gel; Factor V; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophilia | 2004 |
Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Topics: Adult; Apolipoprotein B-100; Apolipoproteins B; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Lipids; Middle Aged; Myocardial Infarction; Postmenopause; Practice Guidelines as Topic; Risk; Single-Blind Method; Triglycerides | 2004 |
Elevated plasma homocysteine: cause or consequence of myocardial infarction?
Topics: Case-Control Studies; Creatinine; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Serum Albumin; Smoking | 2004 |
Cardiovascular risk markers in hemodialysis patients.
Topics: Aged; Cardiovascular Diseases; Creatine Kinase; Creatine Kinase, MB Form; Female; Homocysteine; Humans; Isoenzymes; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Renal Dialysis; Risk Factors; Troponin I; Uremia | 2004 |
[Homocystein and cardiovascular risk: is dosage useful?].
Topics: Adult; Coronary Artery Disease; DNA Mutational Analysis; Genetic Carrier Screening; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Protein S Deficiency; Prothrombin; Recurrence; Risk Factors; Thrombophilia | 2004 |
Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria.
Topics: Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Female; Folic Acid; Homocysteine; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Nigeria; Risk Factors; Stroke; Triglycerides; Vitamin B 12 | 2004 |
Cardiovascular diseases and hyperhomocysteinemia.
Topics: Homocysteine; Humans; Myocardial Infarction; Myocardial Ischemia; Risk Factors | 2005 |
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin I | 2005 |
Serum homocysteine concentration in patients with acute MI and chronic IHD.
Topics: Acute Disease; Adult; Analysis of Variance; Bangladesh; Case-Control Studies; Chronic Disease; History, 18th Century; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia | 2005 |
Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Topics: Adult; Age Factors; Aged; Alleles; Angiography; Arteriosclerosis; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cholesterol; Coronary Artery Disease; Female; Gene Frequency; Genotype; Homocysteine; Humans; Lactones; Lipid Metabolism; Male; Middle Aged; Models, Chemical; Myocardial Infarction; Polymorphism, Genetic; Regression Analysis; Time Factors | 2004 |
The serial changes in plasma homocysteine levels and it's relationship with acute phase reactants in early postmyocardial infarction period.
Topics: Acute-Phase Proteins; Apolipoproteins; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Severity of Illness Index; Time Factors; Triglycerides | 2005 |
Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Regression Analysis | 2005 |
Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?
Topics: Aged; Analysis of Variance; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Linear Models; Male; Myocardial Infarction; Prognosis; Spain; Survival Analysis | 2005 |
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Topics: Aged; Analysis of Variance; Angina, Unstable; Biomarkers; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myoglobin; Prognosis; Recurrence; Risk Assessment; Risk Factors; Troponin I | 2005 |
Effects of marathon running on plasma total homocysteine concentrations.
Topics: Adult; Blood Glucose; Body Composition; Fasting; Fatty Acids, Nonesterified; Folic Acid; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Risk Factors; Running; Vitamin B 12; Waist-Hip Ratio | 2005 |
Impact of elevated plasma total homocysteine concentration on coronary atherosclerosis in Chinese patients with acute myocardial infarction undergoing primary coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Female; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Sex Factors | 2005 |
Acute myocardial infarction in young patients: nutritional status and biochemical factors.
Topics: Acute-Phase Proteins; Adult; Age Factors; Aged; Case-Control Studies; Homocysteine; Humans; Iron; Length of Stay; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Nutritional Status; Triglycerides | 2005 |
[Significance of homocysteines in the development of acute myocardial infarction].
Topics: Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Homocysteine; Humans; Myocardial Infarction; Risk Factors; Severity of Illness Index | 2005 |
Homocysteine level in patients with established transmural myocardial infarction.
Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2005 |
[Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
Topics: Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment | 2005 |
Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families.
Topics: Age of Onset; Atherosclerosis; Family Health; Female; Fibrinogen; Genetic Markers; Genotype; Homocysteine; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Pedigree; Risk Factors; Thrombosis | 2005 |
Homocysteine and its effects on in-stent restenosis.
Topics: Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Models, Biological; Myocardial Infarction; Stents | 2005 |
Homocysteine trials--clear outcomes for complex reasons.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methylation; Myocardial Infarction; Secondary Prevention; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2006 |
Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fasting; Female; Health Surveys; Heart Failure; Homocysteine; Humans; Insulin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Regression Analysis; Risk Factors; United States | 2006 |
The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study.
Topics: Age Factors; Biomarkers; Blood Pressure; Case-Control Studies; Cholesterol; Female; Homocysteine; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Retrospective Studies; Risk Factors; Sex Factors; Smoking | 2006 |
[An association with the values of homocystein with the course of a postinfarct period in patients of different age].
Topics: Adult; Aged; Angina Pectoris; Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2006 |
Homocysteine levels in Pakistanis with myocardial infarction and normal healthy subjects.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Chi-Square Distribution; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Pakistan; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Rate | 2006 |
Serum osteoprotegerin in young survivors of myocardial infarction.
Topics: Adult; Blood Coagulation Factors; Case-Control Studies; CD40 Ligand; Glycoproteins; Homocysteine; Humans; Middle Aged; Myocardial Infarction; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Survivors; Thrombin | 2006 |
Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values; Tunica Intima; Tunica Media | 2006 |
[The uses of clinical studies].
Topics: Cardiovascular Diseases; Drug Industry; Homocysteine; Humans; Myocardial Infarction; Risk Factors | 2006 |
Role of endothelial function and inflammation in patients with cardiovascular risk factors, with and without a history of myocardial infarction.
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Myocardial Infarction; Risk Factors; Statistics, Nonparametric; Ultrasonography | 2007 |
[Better prognosis for stroke patients].
Topics: Aged, 80 and over; Bias; Dose-Response Relationship, Drug; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Vitamin B 12; Vitamin B 6 | 2006 |
Plasma homocysteine level and myocardial infarction: how high is high enough to need intervention?
Topics: Animals; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Myocardial Infarction; Prognosis; Risk Factors; Vitamin B Complex | 2006 |
Determinants of plasma homocysteine in relation to hematological and biochemical variables in patients with acute myocardial infarction.
Topics: Adult; Aged; Biomarkers; Blood Cell Count; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Sex Factors; Vitamins | 2006 |
[Homocysteine as a cardiovascular marker and risk factor].
Topics: Cause of Death; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Myocardial Infarction; Risk Factors; Secondary Prevention; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2006 |
Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
Topics: Aged; Arginine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Statistics, Nonparametric; Stereoisomerism | 2007 |
Homocysteine and outcome in young patients with acute coronary syndromes.
Topics: Age Factors; Cohort Studies; Comorbidity; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Sex Distribution; Spain; Stroke; Survival Analysis | 2007 |
Association of cardiovascular risk factors and disease with depression in later life.
Topics: Age of Onset; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Cross-Sectional Studies; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Homocysteine; Humans; Male; Myocardial Infarction; Risk Factors; Stroke; Surveys and Questionnaires; Triglycerides | 2007 |
[In patients with coronary artery disease and left ventricular contractile insufficiency the pathogenicity of smoking associates with imbalance in metabolism of homocysteine].
Topics: Adult; Comorbidity; Coronary Angiography; Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Smoking; Stroke Volume; Ventricular Dysfunction, Left | 2006 |
Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Coronary Artery Disease; Female; Hemoglobins; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Serum Albumin; Time Factors | 2007 |
Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Homocysteine; Humans; Male; Methylmalonic Acid; Myocardial Infarction; Odds Ratio; Prognosis; Recurrence; Time Factors; Transcobalamins; Vitamin B 12; Vitamin B 12 Deficiency | 2008 |
MTHFR Gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients.
Topics: Adult; Age Factors; Diet; Dietary Supplements; Folic Acid; Gene Frequency; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Riboflavin; Vitamin B 12; Vitamin B Complex | 2007 |
Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cohort Studies; Creatinine; Female; Folic Acid; Germany; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Pyridoxal Phosphate; Surveys and Questionnaires | 2007 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Myocardial Ischemia; Parents; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Siblings | 2008 |
Two models of homocysteine behavior in acute myocardial infarction.
Topics: Aged; Homocysteine; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction; Risk Factors; Time Factors | 2008 |
Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction.
Topics: Adult; Case-Control Studies; Coronary Angiography; Coronary Vessels; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide | 2008 |
Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Sweden | 2008 |
Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Treatment Outcome | 2008 |
Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Asian People; Biomarkers; Electrocardiography; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Philippines; Risk Factors; Survival Analysis | 2008 |
Association of elevated plasma homocysteine levels with impaired ST-segment resolution after fibrinolytic therapy in acute ST-elevation myocardial infarction.
Topics: Aged; Biomarkers; Cohort Studies; Electrocardiography; Female; Fibrinolytic Agents; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2008 |
Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders.
Topics: Aged; Atherosclerosis; Cohort Studies; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Retinal Vein Occlusion; Thrombosis | 2008 |
Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.
Topics: Adult; Amino Acids, Sulfur; Aminobutyrates; Coronary Disease; Diseases in Twins; Female; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Pregnancy; Twins, Monozygotic | 1983 |
A study of cardiovascular risk in heterozygotes for homocystinuria.
Topics: Adult; Aged; Cerebrovascular Disorders; Female; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Myocardial Infarction; Risk | 1981 |
[Homocysteinemia as a risk factor for myocardial infarct--the importance of age and of the homocysteinemia levels].
Topics: Adult; Aging; Case-Control Studies; Confidence Intervals; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors | 1995 |
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.
Topics: Adult; Arteriosclerosis; Case-Control Studies; Cerebrovascular Disorders; Female; Finland; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Prospective Studies; Regression Analysis; Risk Factors | 1994 |
Role of plasma homocyst(e)ine in arterial occlusive diseases.
Topics: Arterial Occlusive Diseases; Homocysteine; Humans; Myocardial Infarction; Prospective Studies; Risk Factors | 1994 |
[Homocysteinemia as a risk factor for early myocardial infarct--a case-control study].
Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Male; Methionine; Myocardial Infarction; Portugal; Risk Factors; Time Factors | 1994 |
[Increased homocysteine level--a risk factor for myocardial infarct?].
Topics: Homocysteine; Humans; Myocardial Infarction; Risk Factors | 1993 |
Serum total homocysteine and coronary heart disease.
Topics: Adolescent; Adult; Case-Control Studies; Child; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Norway; Prospective Studies; Regression Analysis; Risk Factors | 1995 |
Prevention of myocardial infarction by vitamin B6.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Pyridoxine; Retrospective Studies; Rheumatic Diseases; Texas; Vitamin B Deficiency | 1995 |
Laboratory assessment of mild hyperhomocysteinemia as an independent risk factor for occlusive vascular diseases.
Topics: Arteriosclerosis; Homocysteine; Humans; Myocardial Infarction; Risk Factors | 1996 |
Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
Topics: Case-Control Studies; Diet; Diet Surveys; Fasting; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Methionine; Methylation; Middle Aged; Myocardial Infarction; Odds Ratio; Pyridoxine; Risk Factors; Vitamin B 12 | 1996 |
Serial measures of plasma homocyst(e)ine after acute myocardial infarction.
Topics: Acute-Phase Reaction; Adult; Aged; C-Reactive Protein; Female; Follow-Up Studies; Homocysteine; Homocystine; Humans; Male; Middle Aged; Myocardial Infarction | 1996 |
A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Diet; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pyridoxal Phosphate; Pyridoxine; Risk Factors | 1996 |
Genes, greens, and homocysteine.
Topics: Angina Pectoris; Arteriosclerosis; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Prospective Studies; Pyridoxine; Risk Factors; Vitamin B 12 | 1996 |
Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study.
Topics: Aged; Case-Control Studies; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 1996 |
Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.
Topics: Adult; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Comorbidity; Coronary Disease; France; Homocysteine; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Odds Ratio; Risk; Risk Factors; Smoking; Survivors | 1996 |
Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.
Topics: Adult; Aged; Aged, 80 and over; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Physicians; Polymorphism, Genetic; Risk Factors; United States | 1996 |
Heart attacks and homocysteine.
Topics: Homocysteine; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic | 1996 |
[Familial hyperhomocysteinemia with early development of atherosclerosis].
Topics: Adult; Aged; Arteriosclerosis; Child; Child, Preschool; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Vitamin B 12 | 1996 |
A woman who had a stroke, then a myocardial infarction.
Topics: Adult; Carotid Artery Thrombosis; Carotid Artery, Internal; Cerebrovascular Disorders; Coronary Thrombosis; Female; Homocysteine; Humans; Hyperlipoproteinemias; Lipoprotein(a); Myocardial Infarction | 1997 |
Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.
Topics: Adult; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 1997 |
Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study.
Topics: Aged; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Carotid Stenosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Medical History Taking; Middle Aged; Myocardial Infarction; Netherlands; Prevalence | 1997 |
Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.
Topics: Age of Onset; Aged; Bilirubin; Case-Control Studies; Cholesterol, HDL; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hypertension; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Smoking; Survivors; Utah | 1997 |
Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C.
Topics: Adult; Arteriosclerosis; Cholesterol, HDL; Factor V; Homocysteine; Humans; Male; Mutation; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Plasminogen Inactivators; Protein C; Risk Factors; Thrombosis; Triglycerides | 1997 |
C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group.
Topics: Adolescent; Adult; Alanine; Alleles; Europe; Gene Frequency; Genetics, Population; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Valine | 1998 |
Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels.
Topics: Aged; Coronary Disease; Exercise; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Treatment Outcome | 1998 |
Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cerebrovascular Disorders; Cohort Studies; Female; Homocysteine; Humans; Male; Myocardial Infarction; Netherlands; Odds Ratio; Risk; Risk Factors | 1999 |
The heart attackers.
Topics: Adult; Aged; Bacterial Infections; Birth Weight; Blood Pressure; Diet; Homocysteine; Humans; Hypercholesterolemia; Middle Aged; Myocardial Infarction; Risk Factors; United States; Virus Diseases | 1997 |
[A hyperhomocysteinemia study in a population with a familial factor for acute myocardial infarct and sudden cardiac death at a young age].
Topics: Adult; Age Factors; Aged; Case-Control Studies; Chi-Square Distribution; Death, Sudden, Cardiac; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Characteristics | 1999 |
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Female; Homocysteine; Humans; Middle Aged; Myocardial Infarction; Postmenopause; Prospective Studies; Risk | 1999 |
Heart attacks: exploring new preventive strategies.
Topics: Adult; Aged; Ascorbic Acid; Diet; Homocysteine; Humans; Lipids; Middle Aged; Myocardial Infarction; Risk Factors; Sri Lanka | 1998 |
Serum total homocysteine and coronary heart disease: prospective study in middle aged men.
Topics: Adult; Age Factors; Biomarkers; Case-Control Studies; Coronary Disease; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Prospective Studies; Risk Factors | 1999 |
Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction.
Topics: Age Distribution; Age of Onset; Aged; Case-Control Studies; Confidence Intervals; Female; Health Surveys; Homocysteine; Humans; Incidence; Male; Mass Screening; Middle Aged; Myocardial Infarction; Norway; Odds Ratio; Pteroylpolyglutamic Acids; Reference Values; Risk Assessment; Risk Factors; Sex Distribution | 1999 |
[Hyperhomocysteinemia].
Topics: Colestipol; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Myocardial Infarction; Risk Factors | 1999 |
An alternative view of homocysteine.
Topics: Arterial Occlusive Diseases; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Myocardial Infarction; Risk Factors | 1999 |
Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes.
Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; Chest Pain; Cholesterol; Cholesterol, HDL; Chromatography, High Pressure Liquid; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Factor VIIa; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Smoking; Thrombin | 2000 |
Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Examination Survey.
Topics: Age Distribution; Black People; Cholesterol; Comorbidity; Diabetes Mellitus; Educational Status; Female; Folic Acid; Homocysteine; Homocystine; Humans; Hypertension; Male; Mexico; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nutrition Surveys; Odds Ratio; Prevalence; Risk Assessment; Sex Distribution; Smoking; United States; Vitamin B 12; White People | 2000 |
Genetic polymorphism of 5,10-methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population.
Topics: Cohort Studies; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Risk Factors; Vitamins | 2000 |
Plasma homocysteine levels in acute coronary syndromes.
Topics: Adult; Aged; Angina, Unstable; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Vitamin B 12 | 1999 |
Sample size to test for interaction between a specific exposure and a second risk factor in a pair-matched case-control study.
Topics: Algorithms; Case-Control Studies; Data Interpretation, Statistical; Homocysteine; Humans; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Sample Size; Smoking | 2000 |
[PS on homocysteine as a risk factor of cardiovascular disease].
Topics: Biomarkers; Homocysteine; Humans; Myocardial Infarction; Vitamin B 12 | 2000 |
[Prognosis significance of blood homocysteine after myocardial infarction].
Topics: Homocysteine; Humans; Middle Aged; Myocardial Infarction; Prognosis | 2000 |
Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction.
Topics: Alcohol Drinking; Biomarkers; Homocysteine; Humans; Incidence; Myocardial Infarction; Pteroylpolyglutamic Acids; Risk Factors; Smoking | 2000 |
Increased plasma homocysteine is an independent predictor of new coronary events in older persons.
Topics: Aged; Aged, 80 and over; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Vitamin B 12 | 2000 |
Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Angina, Unstable; Death, Sudden, Cardiac; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Osmolar Concentration; Prognosis; Proportional Hazards Models; Risk Factors; Time Factors | 2000 |
Elevation of plasma homocysteine levels associated with acute myocardial infarction.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Aged; Biomarkers; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Time Factors | 2000 |
New risk markers for predicting vascular disease--help or hindrance?
Topics: Biomarkers; Cardiovascular Diseases; Cholesterol; Homocysteine; Humans; Myocardial Infarction; Risk Factors | 2000 |
Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes.
Topics: Angina, Unstable; Aspartate Aminotransferases; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Creatine Kinase; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Hydroxybutyrate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Myocardium; Prognosis; Retrospective Studies; Severity of Illness Index; Troponin T | 2000 |
[The mechanisms of hyperhomocysteinemia in coronary heart disease].
Topics: Adult; Aged; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1998 |
Effect of heterozygosity for the methionine synthase 2756 A-->G mutation on the risk for recurrent cardiovascular events.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Disease-Free Survival; Erythrocytes; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Homocysteine; Humans; Incidence; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors | 2000 |
Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.
Topics: Adult; Cholesterol; Coronary Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Triglycerides | 2000 |
Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: comparison to controls without personal and family history of atherosclerosis.
Topics: Analysis of Variance; Apolipoproteins E; Arteriosclerosis; Case-Control Studies; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prevalence; Risk Factors; Survivors | 2001 |
Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes.
Topics: Acute Disease; Analysis of Variance; Angina, Unstable; C-Reactive Protein; Coronary Care Units; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Patient Admission; Statistics, Nonparametric | 2001 |
Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden.
Topics: Case-Control Studies; Female; Homocysteine; Homozygote; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prevalence; Prospective Studies; Risk Factors; Sweden | 2001 |
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Topics: Algorithms; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Circadian Rhythm; Clinical Trials as Topic; Cohort Studies; Europe; Evaluation Studies as Topic; Female; Homocysteine; Hormone Replacement Therapy; Humans; Inflammation; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Obesity; Predictive Value of Tests; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Smoking; Stroke; United States | 2001 |
Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction.
Topics: Adult; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Turkey | 2001 |
Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction.
Topics: Adult; Aged; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 2001 |
Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia.
Topics: Adolescent; Adult; Age of Onset; Alleles; Case-Control Studies; Coronary Disease; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors | 2001 |
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Recurrence; Tissue Plasminogen Activator; von Willebrand Factor | 2001 |
The role of cysteine and homocysteine in venous and arterial thrombotic disease.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Cysteine; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Reference Values; Thrombosis; Venous Thrombosis | 2001 |
Serum homocysteine does not associate with uncomplicated coronary heart disease.
Topics: Aged; Angina Pectoris; Coronary Disease; Finland; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors | 2001 |
Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.
Topics: Adult; Age of Onset; Analysis of Variance; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2001 |
Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.
Topics: Age Factors; Aged; Arterial Occlusive Diseases; Blood Glucose; C-Reactive Protein; Case-Control Studies; Cholesterol; Cohort Studies; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Lipoproteins, LDL; Male; Myocardial Infarction; Peripheral Vascular Diseases; Risk Factors; Sex Factors; Triglycerides | 2001 |
Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Arterial Occlusive Diseases; Case-Control Studies; Cerebrovascular Disorders; China; Coronary Artery Disease; Cystathionine beta-Synthase; Enzymes; Female; Gene Frequency; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 2001 |
Conditional risk factors in men with previous myocardial infarction: relevance of C3 and homocysteine.
Topics: Aged; Case-Control Studies; Complement C3; Homocysteine; Humans; Middle Aged; Myocardial Infarction; Risk Factors; Statistics, Nonparametric | 2001 |
Nutrition. B vitamins.
Topics: Age Factors; Alzheimer Disease; Diet; Homocysteine; Humans; Myocardial Infarction; Vitamin B 12; Vitamin B 6 | 2001 |
Multiple panel of biomarkers for TIA/stroke evaluation.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Autoantibodies; Biomarkers; Diagnosis, Differential; Disease Progression; Female; Glutamic Acid; Glycine; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Neuroprotective Agents; Predictive Value of Tests; Receptors, N-Methyl-D-Aspartate; Stroke; Tomography, X-Ray Computed | 2002 |
Homocysteine, vitamin B6, and vascular disease in AD patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angina Pectoris; Brain Infarction; Coronary Disease; Female; Heart Failure; Homocysteine; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Odds Ratio; Pyridoxal Phosphate; Stroke; Vascular Diseases; Vitamin B 6 | 2002 |
Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem.
Topics: Adolescent; Adult; Case-Control Studies; Cholesterol; Coronary Disease; Family Health; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Israel; Male; Myocardial Infarction; Risk Factors; United States | 2002 |
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Regression Analysis; Risk Factors; United States | 1992 |
Failure to detect homocysteine in the acid-hydrolysed plasmas of recent myocardial infarct patients.
Topics: Amino Acids; Chromatography; Electrophoresis, Polyacrylamide Gel; Homocysteine; Humans; Hydrolysis; Male; Middle Aged; Myocardial Infarction | 1991 |
Influence of hydrolysis on plasma homocysteine determination in healthy subjects and patients with myocardial infarction.
Topics: Adult; Aged; Chromatography, Ion Exchange; Female; Homocysteine; Homocystine; Humans; Hydrolysis; Male; Middle Aged; Myocardial Infarction | 1991 |
Plasma glucosamine and galactosamine in ischemic heart disease.
Topics: Adult; Arteriosclerosis; Cholesterol; Chromatography, Ion Exchange; Coronary Disease; Galactosamine; Glucosamine; Glycoproteins; Glycosaminoglycans; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values | 1990 |
Homocysteine content of plasma proteins in ischemic heart disease.
Topics: 2-Aminoadipic Acid; Adult; Amino Acids; Blood Proteins; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 1988 |
Homocysteine thiolactone in arteriosclerosis and cancer.
Topics: Adenocarcinoma; Adult; Aged; Arteriosclerosis; Chromatography, Ion Exchange; Chromatography, Thin Layer; Colonic Neoplasms; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasms; Thymoma; Thymus Neoplasms | 1988 |